Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms
Debra Van Egeren, Baransel Kamaz, Shichen Liu, Maximilian Nguyen, Christopher R. Reilly, Maria Kalyva, Daniel J. DeAngelo, Ilene Galinsky, Martha Wadleigh, Eric S. Winer, Marlise R. Luskin, Richard M. Stone, Jacqueline S. Garcia, Gabriela Hobbs, Franziska Michor, Isidro Cortés‐Ciriano, Ann Mullally, Sahand Hormoz
Topics & Concepts
Essential thrombocythemiaBone marrowPolycythemia veraMyeloproliferative DisordersHaematopoiesisCD34BiologyMutationProgenitor cellMyeloidCancer researchMyelopoiesisPopulationStem cellImmunologyGeneMedicineGeneticsEnvironmental healthMyeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia ResearchEosinophilic Disorders and Syndromes